Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4245992

Cn1c(N)ncc(CCc2ccccc2)c1=O.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 4/20 0.46
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP1A2 P05177 3/20 0.38
ALDH1A1 P00352 3/20 0.38
CYP3A4 P08684 2/20 0.38
TSHR P16473 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP2C9 P11712 1/20 0.38
GNRHR P30968 1/20 0.38
CYP2D6 P10635 2/20 0.38
CTRC Q99895 2/20 0.37
CMA1 P23946 1/20 0.37
PRCP P42785 2/20 0.37
PLA2G4A P47712 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
ADORA2B P29275 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8231301 0.90 BACE1 (0.50) BACE1MEN1KMT2ACYP1A2ALDH1A1
Trifluoroacetic Acid SCHEMBL4248535 0.77 MEN1 (0.51) BACE1MEN1KMT2ACYP1A2ALDH1A1
Trifluoroacetic Acid SCHEMBL4249860 0.76 BACE1 (0.46) BACE1MEN1KMT2AGNRHRPLA2G4A
Trifluoroacetic Acid SCHEMBL4242063 0.75 KMT2A (0.49) BACE1MEN1KMT2ACYP1A2ALDH1A1
Trifluoroacetic Acid SCHEMBL4245210 0.75 AOC3 (0.44) BACE1
Trifluoroacetic Acid SCHEMBL20262609 0.70 FFAR1 (0.59) ALDH1A1TSHRSMN1; SMN2
SCHEMBL8237842 0.70 BACE1 (0.62) BACE1
Trifluoroacetic Acid SCHEMBL4247367 0.68 BACE1 (0.51) BACE1MEN1KMT2AALDH1A1
Trifluoroacetic Acid SCHEMBL16700179 0.68 KMT2A (0.49) BACE1MEN1KMT2AADORA2B
Trifluoroacetic Acid SCHEMBL15568420 0.66 ALDH1A1 (0.51) KMT2AALDH1A1TSHRSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215801-A9 Novel 2-Aminopyrimidinone Derivatives And Their Use ASTRAZENECA AB, SODERTAIJE, SWEDENASTEX THEREAPEUTICS LTD (GB) 2009-08-27 US claimed
US-20080255164-A1 Novel 2-Aminopyrimidinone Derivatives And Their Use ASTRAZENECA AB (SE) 2008-10-16 US claimed
EP-1951680-A1 NOVEL 2-AMINOPYRIMIDINONE DERIVATIVES AND THEIR USE Astra Zeneca AB (SE) 2008-08-06 EP claimed
WO-2007058580-A1 NOVEL 2-AMINOPYRIMIDINONE DERIVATIVES AND THEIR USE ASTRAZENECA AB (SE) 2007-05-24 WO claimed
US-20090215801-A9 Novel 2-Aminopyrimidinone Derivatives And Their Use ASTRAZENECA AB, SODERTAIJE, SWEDENASTEX THEREAPEUTICS LTD (GB) 2009-08-27 US disclosed
US-20080255164-A1 Novel 2-Aminopyrimidinone Derivatives And Their Use ASTRAZENECA AB (SE) 2008-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215801-A9 Novel 2-Aminopyrimidinone Derivatives And Their Use PSEN2, PSEN1, MAPT BACE1 9/4885MEN1 4103/4885KMT2A 2006/4885
US-20080255164-A1 Novel 2-Aminopyrimidinone Derivatives And Their Use PSEN2, PSEN1, MAPT BACE1 9/4885MEN1 4103/4885KMT2A 2006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.